Effects of a Province-wide Triaging System for TIA: The ASPIRE Intervention
Citation Manager Formats
Make Comment
See Comments

Abstract
Background Urgent transient ischemic attack (TIA) management to reduce stroke recurrence is challenging, particularly in rural and remote areas. In Alberta, Canada despite an organized stroke system, data from 1999—2000 suggested that stroke recurrence after TIA was as high as 9.5% at 90 days. Our objective was to determine if a multi-faceted population based intervention resulted in a reduction in recurrent stroke following TIA.
Methods In this quasi-experimental health services research intervention study we implemented a TIA management algorithm across the entire province, centered around a 24-hour physician’s TIA Hotline as well as public and health provider education on TIA. From administrative databases we linked emergency department discharge abstracts to hospital discharge abstracts to identify incident TIAs and recurrent strokes at 90 days across a single payer system with validation of recurrent stroke events. The primary outcome was recurrent stroke; with a secondary composite outcome of recurrent stroke, acute coronary syndrome, and all cause death. We used an interrupted time series regression analysis of age and sex-adjusted stroke recurrence rates after TIA incorporating a two-year pre-implementation period (2007-2009), a 15 month implementation period, and a two-year post-implementation period (2010-2012). Logistic regression was used to examine outcomes that did not fit the time series model.
Results We assessed 6 715 patients pre- and 6 956 patients post-implementation. The 90-day stroke recurrence rate in the pre-ASPIRE period was 4.5% compared to 5.3% during the post-ASPIRE period. There was neither a step change (estimate 0.38; p=0.65) nor slope change (parameter estimate 0.30; p=0.12) in recurrent stroke rates associated with the ASPIRE intervention implementation period. Adjusted all-cause mortality (OR 0.71 95%CI [0.56, 0.89]) was significantly lower following the ASPIRE intervention.
Conclusions The ASPIRE TIA triaging and management interventions did not further reduce stroke recurrence in the context of an organized stroke system. The apparent lower mortality post intervention may be related to improved surveillance following events identified as TIAs but secular trends cannot be excluded.
- Received May 4, 2022.
- Accepted in final form February 3, 2023.
- © 2023 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Emily Gilmore and Dr. Rachel Beekman
► Watch
Related Articles
- No related articles found.


